CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 122 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2023. The put-call ratio across all filers is 1.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $639,401 | -31.3% | 29,290 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $931,129 | +30.3% | 29,290 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $714,383 | -22.7% | 29,290 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $923,807 | +90.1% | 29,290 | +70.4% | 0.00% | +100.0% |
| Q3 2022 | $486,000 | +57.8% | 17,190 | +47.6% | 0.00% | 0.0% |
| Q2 2022 | $308,000 | -89.4% | 11,650 | -85.9% | 0.00% | -83.3% |
| Q1 2022 | $2,900,000 | +8.0% | 82,809 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $2,685,000 | +27.9% | 82,809 | +16.4% | 0.01% | +25.0% |
| Q3 2021 | $2,099,000 | +15.1% | 71,159 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,823,000 | +86.6% | 71,159 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $977,000 | – | 71,159 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |